Pharmacokinetics and Drug Interactions with Zonisamide
Authors:
Open Access
Abstract
Summary: Polypharmacy is a widely employed treatment strategy in epilepsy, particularly for individuals with poorly controlled seizures. Drug combinations should be carefully considered to minimize the potential for unfavorable interactions. Older‐generation antiepileptic drugs (AEDs) are well known for their pharmacokinetic interaction potential, which generally results from alterations in the metabolism of concomitant drugs due to effects on the cytochrome P450 (CYP) and uridine glucuronyl transferase enzyme systems. Newer agents, such as zonisamide, are less likely to cause adverse drug interactions. A series of interaction studies has revealed zonisamide to be without effect on the steady‐state pharmacokinetics of carbamazepine, phenytoin, sodium valproate, or lamotrigine. However, zonisamide is principally inactivated by CYP3A4‐dependent reduction. Consequently, carbamazepine, phenytoin, and phenobarbital all increase its clearance, an interaction that may necessitate a dosage increase, but which will also permit more rapid attainment of steady‐state zonisamide concentrations. Otherwise, zonisamide is essentially devoid of clinically significant interactions with other AEDs, oral contraceptives and, indeed, all other classes of therapeutic agents investigated to date. As a result, it is reasonable to conclude that zonisamide has a favorable pharmacokinetic profile and that it may be a useful and uncomplicated agent when employed as adjunctive therapy in refractory epilepsy.Keywords
This publication has 37 references indexed in Scilit:
- Introduction to zonisamideEpilepsy Research, 2006
- ZonisamideCNS Drugs, 2005
- Zonisamide clinical trials: European experienceSeizure: European Journal of Epilepsy, 2004
- Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizuresSeizure: European Journal of Epilepsy, 2004
- Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy womenClinical Therapeutics, 2004
- Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEpilepsy Research, 2003
- Monotherapy versus Polytherapy for Epilepsy: A Multicenter Double‐Blind Randomized StudyEpilepsia, 2001
- Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidineEuropean Journal of Clinical Pharmacology, 2001
- Topiramate as an Inhibitor of Carbonic Anhydrase IsoenzymesEpilepsia, 2000
- Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and ChildrenEpilepsia, 1999